# Collaborative AI Structural Analysis Guide

## Strategy: Claude + Gemini Collaboration

### Phase Division

#### Gemini Lead Tasks (Google Colab Integration)
**Optimal for:** Computational execution, visualization, Google services

1. **ColabFold Execution**
   - Run AlphaFold2 predictions in Google Colab
   - Generate 3D structures for all vaccine constructs
   - Create structural visualizations
   - Export results in standardized format

2. **Statistical Analysis**
   - Process pLDDT confidence scores
   - Generate structural quality metrics
   - Create comparative analysis visualizations
   - Perform secondary structure predictions

#### Claude Lead Tasks (Automation & Integration)
**Optimal for:** File management, automation, integration

1. **Docking Automation**
   - Prepare receptor structures from PDB database
   - Format ligand structures for docking tools
   - Automate HDOCK submissions
   - Parse and integrate docking results

2. **Results Integration**
   - Combine structural and docking data
   - Generate comprehensive analysis reports
   - Create publication-ready documentation
   - Integrate with existing pipeline results

### Handoff Protocol

#### Gemini -> Claude Handoff
**Deliverables from Gemini:**
- PDB structure files for each construct
- pLDDT confidence score analysis
- Structural quality assessment report
- Visualization files (PyMOL sessions, images)

**File Format Requirements:**
```
structural_results/
|-- pdb_structures/
|   |-- version_1_standard.pdb
|   |-- version_2_alternating.pdb
|   |-- version_3_optimized.pdb
|-- confidence_scores/
|   |-- confidence_analysis.json
|   |-- quality_metrics.csv
|-- structural_report.md
```

#### Claude -> Gemini Handoff
**Deliverables from Claude:**
- Docking results for all target receptors
- Interaction analysis data
- Integrated structural-functional assessment
- Final recommendations for construct optimization

### Success Metrics

**Structural Quality Targets:**
- Average pLDDT > 70 (confident prediction)
- Epitope regions pLDDT > 80 (high confidence)
- Secondary structure content appropriate for immunogenicity

**Docking Success Criteria:**
- TLR4 binding: Delta-G < -8 kcal/mol
- MHC binding: Epitopes positioned in binding grooves
- Stable interaction geometries

### Timeline Estimate
- **Gemini Phase**: 3-4 hours (ColabFold + analysis)
- **Claude Phase**: 2-3 hours (docking + integration)
- **Joint Validation**: 1 hour (cross-review + optimization)
- **Total**: 6-8 hours (vs 12-15 hours single-agent)

